Eran Rotem
CEO & CFOMr. Eran Rotem, CPA, has been the Chief Financial Officer of CollPlant Biotechnologies Ltd. (formerly known as CollPlant Holdings Ltd.) since January 2012 and was its Deputy CEO since November 2017 until November 02, 2026 and also serves as its Chief Executive Officer since November 02, 2026. Mr. Rotem has a broad Financial and Operational experience with Bio-Tech and Industrial companies. Prior to joining Collplant, he served as the Chief Financial Officer at Tefron Ltd. since August 17, 2008. He served as the Chief Financial Officer of NexGen Biofuels Ltd. (formerly Healthcare Technologies Ltd.) from May 2002 to June 30, 2008 and served as its Principal Accounting Officer. He was Chief Financial Officer of Gamida Ltd. He served as the Chief Financial Officer at Laxai Pharma, Ltd. from May 2002 to June 30, 2008 and serves as its Principal Accounting Officer. He served as Senior Manager of Ernst & Young from 1995 to April 2002. Mr. Rotem is a Certified Public Accountant and received his B.A. in Accounting, Finance and Business Administration from the Tel-Aviv College of Management.
Positions
- Company NameCollPlant Biotechnologies Ltd.Stock CodeOPHIPositionCEO & CFOColleagues
- EPElan PennIndependent Director
- OFOren FahimipoorVice President of Operations
- OSOded ShoseyovFounder & Chief Scientist
- BABar AbelisVice President of Legal
- HDHadas Dreiher HorowitzVice President of Human Resources
- YTYehiel TalDirector
- OLOfer LevyMember of the Scientific Advisory Board & Member of the Clinical Advisory Board
- AHAbraham HavronIndependent Director
- SSShay SokerMember of Advisory Board
